转移
受体
细胞迁移
医学
趋化因子受体
癌症研究
癌细胞
趋化性
细胞
肿瘤异质性
癌症
趋化因子
生物
内科学
遗传学
作者
Frank Entschladen,Theodore L. Drell,Kerstin Lang,Jan Joseph,Kurt S. Zaenker
出处
期刊:Lancet Oncology
[Elsevier BV]
日期:2004-04-01
卷期号:5 (4): 254-258
被引量:311
标识
DOI:10.1016/s1470-2045(04)01431-7
摘要
Summary Cancer starts as a localised disease, which, if detected early, can often be treated successfully by removal of the primary tumour. A pernicious progression is the invasion of tumour cells into surrounding tissues, resulting in development of distant metastases. Because active migration of tumour cells is a prerequisite for tumour-cell invasion and metastasis, a pressing goal in tumour biology has been the elucidation of factors regulating the migratory activity of these cells. The most prominent regulatory factors are ligands to serpentine receptors—eg, chemokines and neurotransmitters. Many types of neurotransmitter receptors are expressed on tumour cells, supporting the theory that psychosocial factors are involved in the progression of cancer. Understanding how such receptors regulate migration and the availability of specific receptor antagonists could open up new avenues for chemoprevention of tumour-cell migration and metastatic development.
科研通智能强力驱动
Strongly Powered by AbleSci AI